Company / Net Income
AYTU BIOPHARMA, INC Net Income History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$13.6M
FY2025
5-year range
-$108.8M / -$13.6M
FY2021-FY2025
Trend
+14.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Net Income has increased for 3 consecutive years, from -$109M in FY2022 to -$14M in FY2025.
Based on SEC 10-K filings.
-$14M in FY2025.
Improved from -$17M to -$14M over the past 2 years.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- AYTU BIOPHARMA, INC's net income has grown for 3 consecutive years.
- In FY2025, net income increased 14.4% year-over-year.
- Peak net income was recorded in FY2015.
- Lowest net income in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -1.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$13.6M | +14.4% |
| FY2024 | -$15.8M | +7.1% |
| FY2023 | -$17.1M | +84.3% |
| FY2022 | -$108.8M | -86.6% |
| FY2021 | -$58.3M | -327.9% |
| FY2020 | -$13.6M | -33.7% |
| FY2018 | -$10.2M | +54.7% |
| FY2017 | -$22.5M | +20.1% |
| FY2016 | -$28.2M | -264.9% |
| FY2015 | -$7.7M | -1259.3% |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026